Batch Testing Of All Imported Drugs Floated At House Appropriations Hearing

While food oversight dominated lawmakers' attention, Republicans and Democrats were united on need to onshore more drug manufacturing to the US as FDA Commissioner Robert Califf testified about the agency’s fiscal year 2024 budget request.

Califf testimony at House Appropriations
FDA Commissioner Robert Califf testified on the agency’s fiscal year 2024 budget request • Source: House Appropriations Committee

Batch testing of every imported drug to ensure purity and skirt some of the difficulties of conducting international inspections was raised by the chair of the House appropriations subcommittee that oversees the US Food and Drug Administration funding at a 29 March hearing on the agency’s fiscal year 2024 budget.

“If we were worried about imported drugs …why wouldn’t we as Congress authorize a scheme where every imported drug actually...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership